期刊文献+

有关人乳头瘤病毒预防性疫苗临床试验有效性评估的专家共识 被引量:11

原文传递
导出
摘要 自2006年预防性人乳头瘤病毒(human papillomavirus,HPV)疫苗在美国获批上市后,对宫颈癌的预防进入了一个新的时期,许多国家将HPV疫苗列入国家免疫计划,而目前我国HPV疫苗正处于临床试验阶段,尚未被批准使用。世界卫生组织已经把宫颈癌防治纳入衡量各个国家公共卫生工作成绩的考核指标。我国自2009年开始启动农村妇女宫颈癌检查项目,并纳入国家医改重大公共卫生专项工作,迄今为止共检查妇女2000万,
出处 《中华肿瘤杂志》 CAS CSCD 北大核心 2013年第7期552-554,共3页 Chinese Journal of Oncology
关键词 宫颈肿瘤 人乳头瘤病毒 疫苗 持续感染 有效终点 Uterine cervical neoplasms Human papillomavirus Vaccines Persistent infection Efficacy endpoint
  • 相关文献

参考文献15

  • 1Walboomers 1M,Jacobs MY, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.J Pathol, 1999, 189: 12-19.
  • 2de Sanjose S, Quint WG, Alemany L, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross?sectional worldwide study. Lancet Oncol, 2010, 11: 1048-1056.
  • 3乔友林,张林琦.人乳头瘤病毒引起子宫颈癌机理和人免疫缺陷病毒的发现:2008年诺贝尔生理学/医学奖评述//中国科学院.2009科学发展报告.北京:科学出版社,2009:112-119.
  • 4Moscicki AB, Schiffman M, Kjaer S, et al. Chapter 5: updating the natural history of HPV and anogenital cancer. Vaccine, 2006, 24 Suppl 3 : S3/42-51.
  • 5Ostllr AG. Natural history of cervical intraepithelial neoplasia: a critical review. IntJ Gynecol Pathol, 1993, 12: 186-192.
  • 6Schiffman M, Wentzensen N. Human papillomavirus infection and the multistage carcinogenesis of cervical cancer. Cancer Epidemiol Biomarkers Prev, 2013, 22 :553-560.
  • 7Schiffman M, Castle PE,JeronimoJ, et al. Human papillomavirus and cervical cancer. Lancet, 2007,370:890-907.
  • 8KoshiolJ, lindsay L, Pimenta 1M, et al. Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta?analysis. AmJ Epidemiol, 2008, 168: 123-137.
  • 9Ho GY, Bierman R, Beardsley L, et al. Natural history of cervicovaginal papillomavirus infection in young women. N Eng!J Med, 1998, 338 :423-428.
  • 10Schlecht NF, Platt RW, Duarte-Franco E, et al. Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia.J Nat! Cancer Inst, 2003, 95: 1336- 1343.

同被引文献109

  • 1宫颈癌及癌前病变规范化诊疗指南(试行)[J].中国医学前沿杂志(电子版),2013,5(8):40-49. 被引量:223
  • 2孔北华.规范诊断程序 明确诊断标准——《子宫颈癌诊断》标准解读[J].中国卫生标准管理,2013,4(10):4-7. 被引量:25
  • 3井明霞,陈继明,郭晓青.宫颈癌的早期筛查[J].中国妇幼健康研究,2006,17(6):521-524. 被引量:14
  • 4路文婷,段仙芝,岑尧.宫颈癌流行病学概况[J].内蒙古医学杂志,2007,39(8):967-970. 被引量:49
  • 5Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008 : GLOBOCAN 2008 [ J ]. Int J Cancer, 2010, 127 (12) :2893-2917.
  • 6Ciarrocca K, Jackson LL, De Rossi SS. Human papillomavirus: the fundamentals of HPV for oral health care providers[J]. J Calif Dent Assoc, 2013, 41 (5) :349-355.
  • 7Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide [ J ]. J Pathol, 1999,189 ( 1 ) : 12-19.
  • 8Smith JL. A review of hepatitis E virus[J]. J Food Prot, 2001, 64(4) :572-586.
  • 9Wang SS, Schiffman M, Herrero R, et al. Determinants of human papillomavirus 16 serological conversion and persistence in a population-based cohort of 10 000 women in Costa Rica[ J]. Br J Cancer, 2004, 91 (7) :1269-1274.
  • 10Utba NM. The prevalence of hepatitis E virus in A1-Sadr City- Baghdad[ J]. Clin Lab, 2013, 59 (1-2) : 115-120.

引证文献11

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部